Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Successful treatment of occult pancreatic melanoma using BRAF/MEK inhibitors.

Mizukami Y, Kanemaru H, Nakamura K, Hashigo S, Kajihara I, Miyashita A, Aoi J, Fukushima S, Honda Y, Ihn H.

J Dermatol. 2019 Dec 23. doi: 10.1111/1346-8138.15198. [Epub ahead of print] No abstract available.

PMID:
31872454
2.

MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.

Nakahara S, Fukushima S, Okada E, Morinaga J, Kubo Y, Tokuzumi A, Matsumoto S, Tsuruta-Kadohisa M, Kimura T, Kuriyama H, Miyashita A, Kajihara I, Jinnin M, Ihn H.

J Dermatol Sci. 2019 Nov 30. pii: S0923-1811(19)30365-2. doi: 10.1016/j.jdermsci.2019.11.010. [Epub ahead of print] No abstract available.

PMID:
31843231
3.

The Warburg effect and tumour immune microenvironment in extramammary Paget's disease: overexpression of lactate dehydrogenase A correlates with immune resistance.

Urata K, Kajihara I, Miyauchi H, Mijiddorj T, Otsuka-Maeda S, Sakamoto R, Sawamura S, Kanemaru H, Kanazawa-Yamada S, Makino K, Aoi J, Makino T, Fukushima S, Komohara Y, Ihn H.

J Eur Acad Dermatol Venereol. 2019 Dec 14. doi: 10.1111/jdv.16145. [Epub ahead of print]

PMID:
31838771
4.

A case of overlap syndrome (scleroderma and polymyositis) associated with the development of sudden chest pain due to myocardial damage.

Kaneko A, Kajihara I, Miyashita A, Ihn H.

Drug Discov Ther. 2019;13(5):297-298. doi: 10.5582/ddt.2019.01072.

5.

Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy.

Kimura T, Akamatsu Y, Kajihara I, Fukushima S, Ihn H.

J Dermatol. 2020 Jan;47(1):e1-e2. doi: 10.1111/1346-8138.15096. Epub 2019 Sep 30. No abstract available.

PMID:
31571250
6.

IL-16 expression is increased in the skin and sera of patients with systemic sclerosis.

Kawabata K, Makino T, Makino K, Kajihara I, Fukushima S, Ihn H.

Rheumatology (Oxford). 2019 Aug 3. pii: kez318. doi: 10.1093/rheumatology/kez318. [Epub ahead of print]

PMID:
31377804
7.

Brain abscess in an angiosarcoma patient during a disease-free interval.

Kuriyama H, Kajihara I, Kanemaru H, Nishimura Y, Igata T, Masuguchi S, Imaoka Y, Makino K, Ihn H.

Drug Discov Ther. 2019;13(3):175-176. doi: 10.5582/ddt.2019.01042.

8.

A potential significance of circ_0024169 down regulation in angiosarcoma tissue.

Nakashima S, Jinnin M, Ide M, Kajihara I, Igata T, Harada M, Masuguchi S, Fukushima S, Masuzawa M, Masuzawa M, Amoh Y, Ihn H.

Intractable Rare Dis Res. 2019 May;8(2):129-133. doi: 10.5582/irdr.2019.01034.

9.

A case of scleroderma associated with interstitial neutrophilic granulomatous reaction.

Sawamura S, Kajihara I, Ihn H.

Australas J Dermatol. 2019 Nov;60(4):e338-e340. doi: 10.1111/ajd.13065. Epub 2019 May 2. No abstract available.

PMID:
31049924
10.

Overexpression of cyclin-dependent kinase 4 protein in extramammary Paget's disease.

Urata K, Kajihara I, Myangat TM, Tasaki Y, Otsuka-Maeda S, Sawamura S, Kanazawa-Yamada S, Sakamoto R, Makino K, Aoi J, Igata T, Makino T, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

J Dermatol. 2019 May;46(5):444-448. doi: 10.1111/1346-8138.14858. Epub 2019 Mar 21.

PMID:
30897229
11.

The expression of EpCAM in extramammary Paget's disease.

Yamada-Kanazawa S, Tasaki Y, Kajihara I, Sakamoto R, Maeda-Otsuka S, Ihn H.

Intractable Rare Dis Res. 2019 Feb;8(1):20-23. doi: 10.5582/irdr.2019.01010.

12.

Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis.

Yamada-Kanazawa S, Kajihara I, Kobayashi A, Watanabe C, Ihn H.

Dermatol Ther. 2019 May;32(3):e12859. doi: 10.1111/dth.12859. Epub 2019 Feb 27. No abstract available.

PMID:
30748085
13.

Serum cell-free DNA levels are a useful marker for extramammary Paget disease.

Mijiddorj T, Kajihara I, Tasaki Y, Otsuka-Maeda S, Sakamoto R, Sawamura S, Kanazawa-Yamada S, Egashira S, Inoue K, Makino K, Miyashita A, Aoi J, Igata T, Makino T, Masuguchi S, Fukushima S, Jinnin M, Morinaga J, Ikeda T, Ihn H.

Br J Dermatol. 2019 Sep;181(3):505-511. doi: 10.1111/bjd.17709. Epub 2019 Apr 7.

PMID:
30706452
14.

Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment.

Maeda-Otsuka S, Kajihara I, Tasaki Y, Yamada-Kanazawa S, Sakamoto R, Sawamura S, Masuzawa M, Masuzawa M, Amoh Y, Hoshina D, Abe R, Komohara Y, Ihn H.

J Dermatol Sci. 2019 Feb;93(2):123-132. doi: 10.1016/j.jdermsci.2019.01.005. Epub 2019 Jan 15.

PMID:
30704938
15.

Recurrent Fusion Gene ADCK4-NUMBL in Cutaneous Squamous Cell Carcinoma Mediates Cell Proliferation.

Egashira S, Jinnin M, Makino K, Ajino M, Shimozono N, Okamoto S, Tazaki Y, Hirano A, Ide M, Kajihara I, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H.

J Invest Dermatol. 2019 Apr;139(4):954-957. doi: 10.1016/j.jid.2018.09.030. Epub 2018 Nov 2. No abstract available.

PMID:
30395845
16.

Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.

Kubo Y, Fukushima S, Inamori Y, Tsuruta M, Egashira S, Yamada-Kanazawa S, Nakahara S, Tokuzumi A, Miyashita A, Aoi J, Kajihara I, Tomita Y, Wakamatsu K, Jinnin M, Ihn H.

J Dermatol Sci. 2019 Jan;93(1):33-40. doi: 10.1016/j.jdermsci.2018.10.001. Epub 2018 Oct 6.

PMID:
30318169
17.

Serum cytokine profiles are altered in patients with progressive infantile hemangioma.

Yamashita T, Jinnin M, Makino K, Kajihara I, Aoi J, Masuguchi S, Fukushima S, Ihn H.

Biosci Trends. 2018 Sep 19;12(4):438-441. doi: 10.5582/bst.2018.01118. Epub 2018 Aug 26.

18.

Simple and effective modification of the axial frontonasal flap to prevent flap distortion.

Aoi J, Kajihara I, Masuguchi S, Fukushima S, Ihn H.

J Dermatol. 2019 Jan;46(1):e46-e47. doi: 10.1111/1346-8138.14506. Epub 2018 Jun 15. No abstract available.

PMID:
29905387
19.

Sweet's syndrome with laryngoparalysis due to laryngitis.

Miyamura T, Kajihara I, Makino K, Ihn H.

J Dermatol. 2018 Nov;45(11):e295-e296. doi: 10.1111/1346-8138.14351. Epub 2018 Apr 25. No abstract available.

PMID:
29696681
20.

Expression of aurora kinase A expression in dermatofibrosarcoma protuberans.

Kanamori S, Kajihara I, Kanazawa-Yamada S, Otsuka-Maeda S, Ihn H.

J Dermatol. 2018 Apr;45(4):507-508. doi: 10.1111/1346-8138.14235. No abstract available.

PMID:
29682829
21.

Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts.

Sawamura S, Jinnin M, Inoue K, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Ihn H.

J Dermatol Sci. 2018 Apr;90(1):52-59. doi: 10.1016/j.jdermsci.2017.12.017. Epub 2017 Dec 29.

PMID:
29336866
22.

Bullous dermatosis on legs of elderly: A new clinical entity?

Ishibashi T, Jinnin M, Kajihara I, Fukushima S, Ihn H.

Drug Discov Ther. 2017;11(6):346-348. doi: 10.5582/ddt.2017.01067.

23.

Do scleroderma patients look young?: Evaluation by using facial imaging system.

Sawamura S, Jinnin M, Kajihara I, Makino K, Aoi J, Ichihara A, Makino T, Fukushima S, Ihn H.

Drug Discov Ther. 2017;11(6):342-345. doi: 10.5582/ddt.2017.01059.

24.

Case of pigmented lipofibromatosis in a 27-year-old woman.

Sonoda-Shimada K, Kajihara I, Shimada S, Igata T, Jinnin M, Honda Y, Ihn H.

J Dermatol. 2018 May;45(5):e128-e129. doi: 10.1111/1346-8138.14147. Epub 2017 Nov 27. No abstract available.

PMID:
29178136
25.

Dyskeratosis congenita associated with congenital hypothyroidism.

Noda-Yamashita T, Kajihara I, Kidou M, Ihn H.

J Dermatol. 2018 Apr;45(4):e76-e77. doi: 10.1111/1346-8138.14109. Epub 2017 Oct 23. No abstract available.

PMID:
29058334
26.

Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.

Egashira S, Jinnin M, Ajino M, Shimozono N, Okamoto S, Tasaki Y, Hirano A, Ide M, Kajihara I, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H.

Sci Rep. 2017 Oct 4;7(1):12654. doi: 10.1038/s41598-017-12836-z.

27.

Secukinumab-induced interstitial pneumonia in a patient with psoriasis vulgaris.

Kajihara I, Yamada-Kanazawa S, Maeda-Otsuka S, Jinnin M, Akaike K, Ihn H.

J Dermatol. 2017 Dec;44(12):e322-e323. doi: 10.1111/1346-8138.13986. Epub 2017 Aug 3. No abstract available.

PMID:
28771789
28.

The role of miR-210, E2F3 and ephrin A3 in angiosarcoma cell proliferation.

Nakashima S, Jinnin M, Kanemaru H, Kajihara I, Igata T, Okamoto S, Tazaki Y, Harada M, Masuguchi S, Fukushima S, Masuzawa M, Amoh Y, Masuzawa M, Ihn H.

Eur J Dermatol. 2017 Oct 1;27(5):464-471. doi: 10.1684/ejd.2017.3084.

PMID:
28739548
29.

S100A7 expression levels in coordination with interleukin-8 indicate the clinical response to infliximab for psoriasis patients.

Sato Y, Kajihara I, Yamada-Kanazawa S, Jinnin M, Ihn H.

J Dermatol. 2017 Jul;44(7):838-839. doi: 10.1111/1346-8138.13631. No abstract available.

PMID:
28677139
30.

Intratumor dihydropyrimidine dehydrogenase mRNA expression levels are decreased in extramammary Paget's disease.

Nakamura Y, Kajihara I, Yamada-Kanazawa S, Maeda-Otsuka S, Johno T, Aoi J, Igata T, Masuguchi S, Fukushima S, Jinnin M, Ihn H.

Drug Discov Ther. 2017 Jul 31;11(3):152-155. doi: 10.5582/ddt.2017.01022. Epub 2017 Jul 11.

31.

Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis.

Ide M, Jinnin M, Tomizawa Y, Wang Z, Kajihara I, Fukushima S, Hashizume Y, Asano Y, Ihn H.

Exp Dermatol. 2017 Nov;26(11):1139-1143. doi: 10.1111/exd.13366. Epub 2017 Aug 25.

PMID:
28418584
32.

Serum levels of genomic DNA of α1(I) collagen are elevated in scleroderma patients.

Sawamura S, Jinnin M, Shimbara M, Nakamura K, Kudo H, Inoue K, Nakayama W, Kajihara I, Fukushima S, Ihn H.

J Dermatol. 2017 Aug;44(8):927-931. doi: 10.1111/1346-8138.13838. Epub 2017 Mar 31.

PMID:
28370352
33.

Cutaneous spindle cell adenolipoma on the nose: A rare variant of lipoma.

Sawamura S, Kajihara I, Jinnin M, Honda Y, Ihn H.

J Dermatol. 2017 Jul;44(7):e156-e157. doi: 10.1111/1346-8138.13826. Epub 2017 Mar 24. No abstract available.

PMID:
28342245
34.

Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway.

Yamada-Kanazawa S, Kajihara I, Fukushima S, Jinnin M, Masuzawa M, Masuzawa M, Amoh Y, Hoshina D, Abe R, Ihn H.

Br J Dermatol. 2017 Aug;177(2):456-469. doi: 10.1111/bjd.15303. Epub 2017 May 17.

PMID:
28078663
35.

Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.

Egashira S, Kajihara I, Kanemaru H, Uemura-Kiyohara M, Yamada-Kanazawa S, Nakahara S, Nagamoto E, Fukushima S, Jinnin M, Inoue Y, Ihn H.

J Dermatol. 2017 May;44(5):e103-e104. doi: 10.1111/1346-8138.13693. Epub 2016 Nov 24. No abstract available.

PMID:
27882581
36.

Bromoderma in a pituitary adenoma patient treated with bromocriptine.

Maeda S, Kajihara I, Ogata A, Johno T, Jinnin M, Ihn H.

J Dermatol. 2017 May;44(5):e95-e96. doi: 10.1111/1346-8138.13683. Epub 2016 Nov 14. No abstract available.

PMID:
27859507
37.

Diagnosis of nail psoriasis: evaluation of nail-derived microRNAs as potential novel biomarkers.

Wang Z, Jinnin M, Harada M, Kudo H, Inoue K, Nakayama W, Honda N, Makino K, Kajihara I, Fukushima S, Ihn H.

Eur J Dermatol. 2017 Feb 1;27(1):20-27. doi: 10.1684/ejd.2016.2906.

PMID:
27758763
38.

Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression.

Nakayama W, Jinnin M, Tomizawa Y, Nakamura K, Kudo H, Inoue K, Makino K, Honda N, Kajihara I, Fukushima S, Ihn H.

Rheumatology (Oxford). 2017 Jan;56(1):145-155. doi: 10.1093/rheumatology/kew336. Epub 2016 Oct 15.

PMID:
27744356
39.

Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts.

Nakamura K, Jinnin M, Harada M, Kudo H, Nakayama W, Inoue K, Ogata A, Kajihara I, Fukushima S, Ihn H.

J Dermatol Sci. 2016 Oct;84(1):30-39. doi: 10.1016/j.jdermsci.2016.06.013. Epub 2016 Jul 1.

PMID:
27443953
40.

Systemic lupus erythematosus associated with myasthenia gravis, pemphigus foliaceus and chronic thyroiditis after thymectomy.

Sawamura S, Kajihara I, Makino K, Makino T, Fukushima S, Jinnin M, Oyama B, Hashimoto T, Ihn H.

Australas J Dermatol. 2017 Aug;58(3):e120-e122. doi: 10.1111/ajd.12510. Epub 2016 Jun 7.

PMID:
27270472
41.

Cell division cycle-associated protein 1 as a new melanoma-associated antigen.

Tokuzumi A, Fukushima S, Miyashita A, Nakahara S, Kubo Y, Yamashita J, Harada M, Nakamura K, Kajihara I, Jinnin M, Ihn H.

J Dermatol. 2016 Dec;43(12):1399-1405. doi: 10.1111/1346-8138.13436. Epub 2016 May 30.

PMID:
27237743
42.

Cytokine expression profiles in the sera of cutaneous squamous cell carcinoma patients.

Yamada S, Jinnin M, Kajihara I, Nakashima T, Aoi J, Harada M, Igata T, Masuguchi S, Fukushima S, Ihn H.

Drug Discov Ther. 2016;10(3):172-6. doi: 10.5582/ddt.2016.01032. Epub 2016 May 7.

43.

Small bowel perforation due to indistinguishable metastasis of angiosarcoma: case report and brief literature review.

Uchihara T, Imamura Y, Iwagami S, Kajihara I, Kanemaru H, Karashima R, Ida S, Ishimoto T, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Iyama K, Ihn H, Baba H.

Surg Case Rep. 2016 Dec;2(1):42. doi: 10.1186/s40792-016-0169-y. Epub 2016 May 8.

44.

Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy.

Yamada S, Kajihara I, Johno T, Fukushima S, Jinnin M, Masunaga A, Kohrogi H, Ihn H.

Ann Dermatol. 2016 Apr;28(2):269-70. doi: 10.5021/ad.2016.28.2.269. Epub 2016 Mar 31. No abstract available.

45.

The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus.

Nakamura K, Jinnin M, Kudo H, Inoue K, Nakayama W, Honda N, Kajihara I, Masuguchi S, Fukushima S, Ihn H.

Br J Dermatol. 2016 May;174(5):1030-41. doi: 10.1111/bjd.14385. Epub 2016 Mar 25.

PMID:
26713607
46.

Serum concentrations of Flt-3 ligand in rheumatic diseases.

Nakamura K, Nakatsuka N, Jinnin M, Makino T, Kajihara I, Makino K, Honda N, Inoue K, Fukushima S, Ihn H.

Biosci Trends. 2015 Oct;9(5):342-9. doi: 10.5582/bst.2015.01121.

47.

NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma.

Shimozono N, Jinnin M, Masuzawa M, Masuzawa M, Wang Z, Hirano A, Tomizawa Y, Etoh-Kira T, Kajihara I, Harada M, Fukushima S, Ihn H.

Cancer Res. 2015 Nov 1;75(21):4458-65. doi: 10.1158/0008-5472.CAN-15-0418.

48.

Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment.

Koga A, Kajihara I, Yamada S, Makino K, Ichihara A, Aoi J, Makino T, Fukushima S, Jinnin M, Ihn H.

J Dermatol. 2016 May;43(5):522-5. doi: 10.1111/1346-8138.13178. Epub 2015 Oct 28.

PMID:
26507968
49.

Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma.

Ichigozaki Y, Fukushima S, Jinnin M, Miyashita A, Nakahara S, Tokuzumi A, Yamashita J, Kajihara I, Aoi J, Masuguchi S, Zhongzhi W, Ihn H.

Exp Dermatol. 2016 Jan;25(1):67-9. doi: 10.1111/exd.12868. Epub 2015 Nov 23. No abstract available.

PMID:
26440365
50.

EBI3 Downregulation Contributes to Type I Collagen Overexpression in Scleroderma Skin.

Kudo H, Wang Z, Jinnin M, Nakayama W, Inoue K, Honda N, Nakashima T, Kajihara I, Makino K, Makino T, Fukushima S, Ihn H.

J Immunol. 2015 Oct 15;195(8):3565-73. doi: 10.4049/jimmunol.1402362. Epub 2015 Sep 9.

Supplemental Content

Loading ...
Support Center